Despite its success in treating other cancers, immunotherapy for ovarian cancer only boasts a 6-15% success rate. The reasons behind this disparity are complex, but PhD student, Karla Robles, is determined to change this narrative. Making this research even more critical is the alarming fact that while Black women are less likely to develop ovarian